Furthermore, in the RENCA allograft mouse model, combination treatment significantly increased LMP2 expression, MHC class I expression on the cell surface, and the percentage of CD45+ CD3e+ T cells (Figure 5) and reduced tumor volume (Figure 4). The gene discussed is PTPRC; the disease is neoplasm.